Security key
55279B202
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP)
CUSIP: 55279B202
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Stock, $0.00000002 par value
- Total 13F shares
- 56,055,550
- Total 13F value
- $33,769,440
- Share change
- -32,768,050
- Put/Call ratio
- 19%
- SEC-reported price per share
- $0.60
- Number of holders
- 85
- Value change
- -$85,348,603
- Number of buys
- 48
- Number of sells
- 55
- Shares outstanding
- 29,545,622
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
85
Top holders
10
MEIP full security history
Ownership snapshot
Full 13F holder table
Lite Strategy, Inc. SEC filings
Lite Strategy, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MPM BioImpact LLC
Disclosed value leader
MPM BioImpact LLC
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F
Highest disclosed value: $32,977,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
MPM BioImpact LLC has the largest disclosed position value at $32.98M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MPM BioImpact LLC's linked filing trail.
Disclosed position value
Top 5
MPM BioImpact LLC
$32.98M
First Light Asset Management, LLC
$29.95M
WASATCH ADVISORS LP
$24.94M
NEA Management Company, LLC
$22.78M
BlackRock Finance, Inc.
$17.86M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MPM BioImpact LLC |
13F
Company
|
—
denominator unverified
|
$32,977,000
12,350,971 shares
|
— | 31 Dec 2021 |
| First Light Asset Management, LLC |
13F
Company
|
—
denominator unverified
|
$29,951,000
11,217,426 shares
|
— | 31 Dec 2021 |
| WASATCH ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$24,944,000
9,342,310 shares
|
— | 31 Dec 2021 |
| NEA Management Company, LLC |
13F
Company
|
—
denominator unverified
|
$22,783,000
8,533,072 shares
|
— | 31 Dec 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$17,861,000
6,689,871 shares
|
— | 31 Dec 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$15,405,000
5,769,739 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
85
Shares
56,055,550
Rows available
85
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q1 2022 Across Filers
Q1 2022 holders
85
Q1 2022 holders
85
Holder diff
0
| Investor | Q1 2022 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q1 2022 value | Value change | Value Chg % |
|---|